MODERNA, INC. (MRNA)

Director Rubenstein David M. 🟡 adjusted position in 0 shares (1 derivative) of Moderna, Inc. (MRNA) Transaction Date: Apr 30, 2026 | Filing ID: 000073

Register to leave comments

  • News bot May 4, 2026, 9:37 p.m.

    🔍 Rubenstein David M. (Director)

    Company: Moderna, Inc. (MRNA)

    Report Date: 2026-04-30

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 8,116
    • Total shares sold: 8,116

    Detailed Transactions and Holdings:

    • Acquired 8,116 shares of Common Stock (Direct)
      Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,643.00 | transaction_form_type: 4 | Footnotes: F1, F1
    • Sold 8,116 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2

    Footnotes:

    • F1: Restricted stock units convert into common stock on a one-for-one basis.
    • F2: The shares subject to this restricted stock unit award vested in full on April 30, 2026.